Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

PENUMBRA, INC.

United States·US-MF-000008514

Last updated September 17, 2026

Information

Country
United States
Address
One Penumbra Place, Alameda, United States
LinkedIn
—
Facebook
—
Phone
—
PRRC Contact
Mary Rose
EUDAMED SRN
US-MF-000008514
FDA FEI Number
3013758550
DUNS Number
191077671

Catalogue (1506)

Page 6 of 31
DeviceModel / ReferenceRegistriesClassStatus
Penumbra Coil 400 4004C1145
FDA UDI
Class IIActive
Penumbra System 5MAXDDC115
FDA UDI
Class IIActive
Penumbra Coil 400 4002C1235-A
FDA UDI
Class IIActive
Penumbra System 5MAXACE127
FDA UDI
Class IIActive
Smart Coil 400SMTXSFT3H04
FDA UDI
Class IIActive
Benchmark BMK6F105M
FDA UDI
Class IIActive
RUBY Coil RBY4C2060-A
FDA UDI
Class IIActive
Smart Coil 400SMTXSFT0310
FDA UDI
Class IIActive
Penumbra Coil 400 4002C0960
FDA UDI
Class IIActive
Penumbra Coil 400 4004J12
FDA UDI
Class IIActive
Benchmark BMK6F115
FDA UDI
Class IIActive
Swift Coil System 400SWPC55-A
FDA UDI
Class IIActive
Penumbra Coil 400 4006C0412
FDA UDI
Class IIActive
Smart Coil 400SMTSFT0620
FDA UDI
Class IIActive
RUBY Coil RBY4C1240-A
FDA UDI
Class IIActive
Penumbra Coil 400 4002C0320
FDA UDI
Class IIActive
Penumbra System PST3
EUDAMEDFDA UDI
Class IIActive
RUBY Coil RBY4C0315-B
FDA UDI
Class IIActive
Smart Coil 400SMTHXSFT0410
FDA UDI
Class IIActive
Smart Coil 400SMTSFT0515
FDA UDI
Class IIActive
Penumbra Coil 400 4006C0408-A
FDA UDI
Class IIActive
RUBY Coil RBY2C0825-A
FDA UDI
Class IIActive
Penumbra Coil 400 4006U0201
FDA UDI
Class IIActive
Pod RBYPOD5-A
FDA UDI
Class IIActive
LP Coil System RBYPCLP03
FDA UDI
Class IIActive
Neuron PNML6F088804
FDA UDI
Class IIActive
Smart Coil 400SMTSFT0520
FDA UDI
Class IIActive
Indigo System LITNGFB12XT100-A
FDA UDI
Class IIActive
Penumbra System PST1
FDA UDI
Class IIActive
Smart Coil 400SMTHXSFT3H10
FDA UDI
Class IIActive
Smart Coil 400SMTXSFT1H05
FDA UDI
Class IIActive
Penumbra System 5MAXACE068L125-A
FDA UDI
Class IIActive
Velocity Delivery Microcatheter VEL160090-A
FDA UDI
Class IIActive
Penumbra Coil 400 400PAC25
FDA UDI
Class IIActive
Smart Coil 400SMTSFT0204
FDA UDI
Class IIActive
Neuron PNS5F120H1
FDA UDI
Class IIActive
Neuron PND6F1156
FDA UDI
Class IIActive
Indigo System CAT7STR160KIT-A
FDA UDI
Class IIActive
Pod RBYPOD8-A
FDA UDI
Class IIActive
LP Coil System RBYLP0850
FDA UDI
Class IIActive
Penumbra System 5MAXACE064L120-A
FDA UDI
Class IIActive
Penumbra System 5MAXJET7BL115-A
FDA UDI
Class IIActive
Pod RBYPOD10-A
FDA UDI
Class IIActive
Indigo IAPS3
FDA UDI
Class IIActive
Indigo System CAT3KIT-A
FDA UDI
Class IIActive
Benchmark BMK6F105-A
FDA UDI
Class IIActive
Penumbra Coil 400 4006U0203-A
FDA UDI
Class IIActive
Smart Coil 400SMTSTD1235
FDA UDI
Class IIActive
Indigo System CAT8TORQ85
FDA UDI
Class IIActive
Smart Coil 400SMTXSFT3H12
FDA UDI
Class IIActive

Related Companies

Authorised Representatives

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Recalls (10)

Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.

DateRecall No.ClassStatusReason
Dec 15, 2020Z-0848-2021—terminated

The catheter may become susceptible to distal tip damage during use. Distal tip damage in conjunction with pressurization of contrast injection may result in potential vessel damage, and subsequent patient injury or death.

Dec 15, 2020Z-0851-2021—terminated

The catheter may become susceptible to distal tip damage during use. Distal tip damage in conjunction with pressurization of contrast injection may result in potential vessel damage, and subsequent patient injury or death.

Dec 15, 2020Z-0850-2021—terminated

The catheter may become susceptible to distal tip damage during use. Distal tip damage in conjunction with pressurization of contrast injection may result in potential vessel damage, and subsequent patient injury or death.

Dec 15, 2020Z-0849-2021—terminated

The catheter may become susceptible to distal tip damage during use. Distal tip damage in conjunction with pressurization of contrast injection may result in potential vessel damage, and subsequent patient injury or death.

Jun 9, 2017Z-2702-2017—terminated

Penumbra has identified an issue in these four lots involving a raw material component of the delivery wire. This issue could result in breakage of the delivery wire, which could potentially lead to serious patient injury or death.

Mar 4, 2011Z-1906-2011—terminated

The diameter of a component of the device is out of tolerance specification; the Delivery Pusher pull wire which secures the coil in place can prolapse and allow premature detachment of the coil.

Oct 25, 2010Z-0428-2011—terminated

Reperfusion catheter may fail at the mid-shaft joint and may break off. If the segment cannot be removed, it may result in blocked blood flow, requiring emergency medical treatment.

Sep 22, 2009Z-0001-2010—terminated

Failure-- product can kink or ovalize, which may result in difficulty in catheter advancement or delivery of other devices and damage to catheter, which could lead to patient injury or death as a result of portions being retained in the patient.

Jul 2, 2009Z-2049-2009—terminated

Leakage-- Due to a manufacturing error, some products may have a fold in the innermost layer, causing disruption in the layering process and may result in blow holds or exposed wire braids, which may result in further damage.

Jul 1, 2009Z-2313-2009—terminated

Misbranding--Some products may be identified with the wrong ID band content 'Neuron 6F 070' instead of 'Neuron 6F delivery'

FDA Establishments (1)

Establishments registered with the FDA under this company group, matched by name.

  • Penumbra Inc. Roseville, CA · US FEI 3016591327